curcumin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
curcumin — decreases interleukin-6 concentration
Evidence strength: moderate.Findingreplicated ×8“The results of the linear regression analyses revealed that assignment to the CURC group was associated with significantly lower mean post-trial concentrations of the inflammatory biomarkers, IL-6 (β = −0.52, 95% CI: −1.03,−0.014, p = 0.046) and MCP-1 (β = −0.12, 95% CI: −0.23, −0.015, p = 0.027) controlling for baseline and covariates, compared to the CON group (Table 2 and Table S2).”
Quoted verbatim from Curcumin Confers Anti-Inflammatory Effects in Adults Who Recovered from COVID-19 and Were Subsequently Vaccinated: A Randomized Controlled Trial.. - Study
- RCT
- Duration
- 4 weeks
- Dose
- 500 mg HydroCurc (over 90% curcuminoids complexed with LipiSperse) twice daily vs maltodextrin placebo
- Population
- Adults aged 18 to 65 who had recovered from COVID-19 and subsequently received the primary vaccine series; post-trial concentration adjusted for baseline and covariates
Curcumin Confers Anti-Inflammatory Effects in Adults Who Recovered from COVID-19 and Were Subsequently Vaccinated: A Randomized Controlled Trial.2023PMID:3704938910.3390/nu15071548Industry fundedPermalink
To cite this finding: https://catalystproject.ai/e/01M5S6SFA0EH5C8FC1FJ9X900Y